Fred Princen

1.4k total citations
29 papers, 809 citations indexed

About

Fred Princen is a scholar working on Genetics, Epidemiology and Immunology. According to data from OpenAlex, Fred Princen has authored 29 papers receiving a total of 809 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Genetics, 24 papers in Epidemiology and 9 papers in Immunology. Recurrent topics in Fred Princen's work include Inflammatory Bowel Disease (25 papers), Microscopic Colitis (23 papers) and Immunodeficiency and Autoimmune Disorders (7 papers). Fred Princen is often cited by papers focused on Inflammatory Bowel Disease (25 papers), Microscopic Colitis (23 papers) and Immunodeficiency and Autoimmune Disorders (7 papers). Fred Princen collaborates with scholars based in United States, Belgium and Canada. Fred Princen's co-authors include Sharat Singh, Mark S. Riddle, Jean‐Frédéric Colombel, Rok Seon Choung, Joana Torres, Scott E. Plevy, Anjali Jain, Andrés Yarur, Amar R. Deshpande and Maria A. Quintero and has published in prestigious journals such as Gastroenterology, PLoS ONE and Gut.

In The Last Decade

Fred Princen

26 papers receiving 793 citations

Peers

Fred Princen
Wendy Kampman United States
Richard A. Lirio United States
Filip J. Baert Belgium
Noa Krugliak Cleveland United States
Virginia Solitano Italy
B Huang Canada
P. Rutgeerts Belgium
Romain Altwegg France
Aušrinė Barakauskienė Lithuania
Ole K. Bonderup Denmark
Wendy Kampman United States
Fred Princen
Citations per year, relative to Fred Princen Fred Princen (= 1×) peers Wendy Kampman

Countries citing papers authored by Fred Princen

Since Specialization
Citations

This map shows the geographic impact of Fred Princen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fred Princen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fred Princen more than expected).

Fields of papers citing papers by Fred Princen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fred Princen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fred Princen. The network helps show where Fred Princen may publish in the future.

Co-authorship network of co-authors of Fred Princen

This figure shows the co-authorship network connecting the top 25 collaborators of Fred Princen. A scholar is included among the top collaborators of Fred Princen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fred Princen. Fred Princen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Choung, Rok Seon, Francesca Petralia, Joana Torres, et al.. (2023). Preclinical Serological Signatures are Associated With Complicated Crohn’s Disease Phenotype at Diagnosis. Clinical Gastroenterology and Hepatology. 21(11). 2928–2937.e12. 14 indexed citations
2.
Torres, Joana, Francesca Petralia, Takahiro Sato, et al.. (2020). Serum Biomarkers Identify Patients Who Will Develop Inflammatory Bowel Diseases Up to 5 Years Before Diagnosis. Gastroenterology. 159(1). 96–104. 145 indexed citations
3.
Porter, Chad K., Mark S. Riddle, Ramiro L. Gutiérrez, et al.. (2019). Cohort profile of the PRoteomic Evaluation and Discovery in an IBD Cohort of Tri-service Subjects (PREDICTS) study: Rationale, organization, design, and baseline characteristics. Contemporary Clinical Trials Communications. 14. 100345–100345. 22 indexed citations
4.
Choung, Rok Seon, Francesca Petralia, Takahiro Sato, et al.. (2019). Sa1818 – Innate Immune Dysregulation, Detectable Up to 6 Years Before the Diagnosis of Crohn's Disease, is Significantly Amplified in Patients with a Complicated Phenotype. Gastroenterology. 156(6). S–413. 2 indexed citations
5.
Billiet, Thomas, Isabelle Cleynen, Vera Ballet, et al.. (2017). Evolution of cytokines and inflammatory biomarkers during infliximab induction therapy and the impact of inflammatory burden on primary response in patients with Crohn’s disease. Scandinavian Journal of Gastroenterology. 52(10). 1086–1092. 38 indexed citations
6.
Eswaran, Shanti, Juanita L. Merchant, Amanda Photenhauer, et al.. (2017). Tryptophan Hydroxlase 1 (TPH1) Promoter Genotype but not Serum Serotonin Levels Identify IBS-D Patients More Likely to Benefit from the Low Fodmap Diet. Gastroenterology. 152(5). S69–S69. 4 indexed citations
7.
Billiet, Thomas, Isabelle Cleynen, Vera Ballet, et al.. (2015). Disease burden outweighs the impact of drug concentrations and antibodies to infliximab in primary non-response to infliximab in Crohn's disease patients. 9. 2 indexed citations
8.
Papamichael, Konstantinos, Karolien Claes, Magali de Bruyn, et al.. (2015). Serology panel for prediction relapse after discontinuation of infliximab in patients with Crohn's disease achieving clinical remission. 9. 1 indexed citations
9.
Yarur, Andrés, Anjali Jain, Daniel A. Sussman, et al.. (2015). The association of tissue anti-TNF drug levels with serological and endoscopic disease activity in inflammatory bowel disease: the ATLAS study. Gut. 65(2). 249–255. 178 indexed citations
10.
Billiet, Thomas, Konstantinos Papamichael, Magali de Bruyn, et al.. (2015). A Matrix-based Model Predicts Primary Response to Infliximab in Crohn’s Disease. Journal of Crohn s and Colitis. 9(12). 1120–1126. 47 indexed citations
11.
Choung, Rok Seon, Thomas P. Stockfisch, Fred Princen, et al.. (2015). 78 Longitudinal Status of Serological Markers Predict Crohn's Disease Phenotype Before Diagnosis: A ‘PREDICTS’ Study. Gastroenterology. 148(4). S–22. 7 indexed citations
12.
Lee, Jeeyun, Anjali Jain, Phillip Kim, et al.. (2014). Activated cMET and IGF1R-Driven PI3K Signaling Predicts Poor Survival in Colorectal Cancers Independent of KRAS Mutational Status. PLoS ONE. 9(8). e103551–e103551. 18 indexed citations
13.
Papamichael, Konstantinos, Niels Vande Casteele, Ann Gils, et al.. (2014). Long-Term Outcome of Patients With Crohn’s Disease Who Discontinued Infliximab Therapy Upon Clinical Remission. Clinical Gastroenterology and Hepatology. 13(6). 1103–1110. 63 indexed citations
14.
Casteele, Niels Vande, Scott Hauenstein, Fred Princen, et al.. (2014). Su1394 Prediction of Sustained Remission After Discontinuation of Infliximab in Patients With Crohn's Disease. Gastroenterology. 146(5). S–457. 2 indexed citations
15.
Plevy, Scott E., Mark S. Silverberg, S. Lockton, et al.. (2013). Combined Serological, Genetic, and Inflammatory Markers Differentiate Non-IBD, Crohnʼs Disease, and Ulcerative Colitis Patients. Inflammatory Bowel Diseases. 19(6). 1139–1148. 97 indexed citations
16.
Plevy, Scott E., Steven Lockton, Fred Princen, & Sharat Singh. (2013). 1029 Serological and Inflammatory IBD Marker Prevalence As Function of Age in a Large Cohort of Patients Presenting IBD-Like Gastrointestinal Symptoms. Gastroenterology. 144(5). S–192. 1 indexed citations
17.
Farraye, Francis A., Michelle Brown, Sharat Singh, & Fred Princen. (2012). 108 Blood MicroRNA (miRNA) Expression Patterns Can Identify Inflammatory Bowel Disease (IBD) Patients With Dysplasia and Cancer. Gastroenterology. 142(5). S–26.
18.
Plevy, Scott E., Thomas P. Stockfisch, Steven Lockton, et al.. (2012). 166 Combined Serologic, Genetic, and Inflammatory Markers Can Accurately Differentiate Non-IBD, Crohn's Disease, and Ulcerative Colitis Patients. Gastroenterology. 142(5). S–41.
19.
Lichtenstein, Gary R., Stephan R. Targan, Marla C. Dubinsky, et al.. (2011). Combination of genetic and quantitative serological immune markers are associated with complicated Crohnʼs disease behavior. Inflammatory Bowel Diseases. 17(12). 2488–2496. 59 indexed citations
20.
Lichtenstein, Gary R., Derren Barken, L. V. Eggleston, et al.. (2010). 207 A Novel Algorithm-Based Approach Using Clinical Parameters, Genetic and Serological Markers to Effectively Predict Aggressive Disease Behavior in Patients With Crohn's Disease. Gastroenterology. 138(5). S–38. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wendy Kampman Breakdown of academic impact, for papers by Richard A. Lirio Breakdown of academic impact, for papers by Filip J. Baert Breakdown of academic impact, for papers by Noa Krugliak Cleveland Breakdown of academic impact, for papers by Virginia Solitano Breakdown of academic impact, for papers by B Huang Breakdown of academic impact, for papers by P. Rutgeerts Breakdown of academic impact, for papers by Romain Altwegg Breakdown of academic impact, for papers by Aušrinė Barakauskienė Breakdown of academic impact, for papers by Ole K. Bonderup
Rankless by CCL
2026